2,851
edits
Line 89: | Line 89: | ||
! colspan="1" rowspan="1" |Therapeutic Effects of TMG Administration | ! colspan="1" rowspan="1" |Therapeutic Effects of TMG Administration | ||
! colspan="1" rowspan="1" |Experimental Model | ! colspan="1" rowspan="1" |Experimental Model | ||
|- | |- | ||
| colspan="1" rowspan="1" |Prevents hepatic fat accumulation in ALD | | colspan="1" rowspan="1" |Prevents hepatic fat accumulation in ALD | ||
| colspan="1" rowspan="1" |Male Wistar rats; C57BL/6 mice; Balb/c mice | | colspan="1" rowspan="1" |Male Wistar rats; C57BL/6 mice; Balb/c mice | ||
|- | |- | ||
| colspan="1" rowspan="1" |Preserves/restores hepatic SAM: SAH ratios by regenerating SAM and lowering SAH and homocysteine levels in ALD | | colspan="1" rowspan="1" |Preserves/restores hepatic SAM: SAH ratios by regenerating SAM and lowering SAH and homocysteine levels in ALD | ||
| colspan="1" rowspan="1" | Male Wistar rats; hepatocytes; male C57BL/6 mice | | colspan="1" rowspan="1" | Male Wistar rats; hepatocytes; male C57BL/6 mice | ||
|- | |- | ||
| colspan="1" rowspan="1" |Restores activities of various liver methyltransferases (PEMT, ICMT, PIMT, PRMT) to increase phosphatidylcholine levels, preventing apoptosis and accumulation of damaged proteins, and restoring proteasome activity | | colspan="1" rowspan="1" |Restores activities of various liver methyltransferases (PEMT, ICMT, PIMT, PRMT) to increase phosphatidylcholine levels, preventing apoptosis and accumulation of damaged proteins, and restoring proteasome activity | ||
| colspan="1" rowspan="1" |Male Wistar rats; hepatocytes | | colspan="1" rowspan="1" |Male Wistar rats; hepatocytes | ||
|- | |- | ||
| colspan="1" rowspan="1" |Suppresses the synthesis of DGAT2, a rate-limiting enzyme in triglyceride synthesis, by alleviating ERK1/2 inhibition in ALD | | colspan="1" rowspan="1" |Suppresses the synthesis of DGAT2, a rate-limiting enzyme in triglyceride synthesis, by alleviating ERK1/2 inhibition in ALD | ||
| colspan="1" rowspan="1" |Male C57BL/6 mice | | colspan="1" rowspan="1" |Male C57BL/6 mice | ||
|- | |- | ||
| colspan="1" rowspan="1" |Upregulates antioxidant defense system and improves oxyradical scavenging activity in ALD | | colspan="1" rowspan="1" |Upregulates antioxidant defense system and improves oxyradical scavenging activity in ALD | ||
| colspan="1" rowspan="1" |Male Wistar rats | | colspan="1" rowspan="1" |Male Wistar rats | ||
|- | |- | ||
| colspan="1" rowspan="1" |Prevents/attenuates ER stress in ALD | | colspan="1" rowspan="1" |Prevents/attenuates ER stress in ALD | ||
| colspan="1" rowspan="1" |Male C57BL/6 mice | | colspan="1" rowspan="1" |Male C57BL/6 mice | ||
|- | |- | ||
| colspan="1" rowspan="1" |Exerts hepatoprotection by preserving mitochondrial function in ALD | | colspan="1" rowspan="1" |Exerts hepatoprotection by preserving mitochondrial function in ALD | ||
| colspan="1" rowspan="1" | Male Wistar rats | | colspan="1" rowspan="1" | Male Wistar rats | ||
|- | |- | ||
| colspan="1" rowspan="1" |Restores the serum adiponectin levels in ALD | | colspan="1" rowspan="1" |Restores the serum adiponectin levels in ALD | ||
| colspan="1" rowspan="1" |Mice | | colspan="1" rowspan="1" |Mice | ||
|- | |- | ||
| colspan="1" rowspan="1" |Prevents elevations of CD14, TNFα, COX2, GADD45β, LITAF, JAK3, TLR2, TLR4, IL1β, and PDCD4 and NOS2 mRNA levels in alcoholic liver injury | | colspan="1" rowspan="1" |Prevents elevations of CD14, TNFα, COX2, GADD45β, LITAF, JAK3, TLR2, TLR4, IL1β, and PDCD4 and NOS2 mRNA levels in alcoholic liver injury | ||
| colspan="1" rowspan="1" |Male Wistar rats | | colspan="1" rowspan="1" |Male Wistar rats | ||
|- | |- | ||
| colspan="1" rowspan="1" |Prevents serum ALT and AST activity elevations in models of ALD and MAFLD | | colspan="1" rowspan="1" |Prevents serum ALT and AST activity elevations in models of ALD and MAFLD | ||
| colspan="1" rowspan="1" |Male Wistar rats | | colspan="1" rowspan="1" |Male Wistar rats | ||
|- | |- | ||
| colspan="1" rowspan="1" |Reduces liver oxidant stress, inflammation, and apoptosis in MAFLD | | colspan="1" rowspan="1" |Reduces liver oxidant stress, inflammation, and apoptosis in MAFLD | ||
| colspan="1" rowspan="1" |Male C57BL/6 mice | | colspan="1" rowspan="1" |Male C57BL/6 mice | ||
|- | |- | ||
| colspan="1" rowspan="1" | Remethylates homocysteine, protecting from oxidant stress and restoring phosphatidylcholine generation in MAFLD | | colspan="1" rowspan="1" | Remethylates homocysteine, protecting from oxidant stress and restoring phosphatidylcholine generation in MAFLD | ||
| colspan="1" rowspan="1" |C57BL/6 mice | | colspan="1" rowspan="1" |C57BL/6 mice | ||
|- | |- | ||
| colspan="1" rowspan="1" | Stimulates β-oxidation in livers of MCD diet-induced MAFLD | | colspan="1" rowspan="1" | Stimulates β-oxidation in livers of MCD diet-induced MAFLD | ||
| colspan="1" rowspan="1" |Male Sprague-Dawley rats | | colspan="1" rowspan="1" |Male Sprague-Dawley rats | ||
|- | |- | ||
| colspan="1" rowspan="1" |Alleviates steatosis and increases autophagosomes numbers in mouse livers with MAFLD | | colspan="1" rowspan="1" |Alleviates steatosis and increases autophagosomes numbers in mouse livers with MAFLD | ||
| colspan="1" rowspan="1" |Male C57BL/6 mice; rats | | colspan="1" rowspan="1" |Male C57BL/6 mice; rats | ||
|- | |- | ||
| colspan="1" rowspan="1" |Enhances the conversion of existing WAT to brown adipose tissue through stimulating mitochondrial biogenesis in MAFLD | | colspan="1" rowspan="1" |Enhances the conversion of existing WAT to brown adipose tissue through stimulating mitochondrial biogenesis in MAFLD | ||
| colspan="1" rowspan="1" |Mice | | colspan="1" rowspan="1" |Mice | ||
|- | |- | ||
| colspan="1" rowspan="1" |Alleviates ROS-induced mitochondrial respiratory chain dysfunction in MAFLD | | colspan="1" rowspan="1" |Alleviates ROS-induced mitochondrial respiratory chain dysfunction in MAFLD | ||
| colspan="1" rowspan="1" | Male Sprague-Dawley rats | | colspan="1" rowspan="1" | Male Sprague-Dawley rats | ||
|- | |- | ||
| colspan="1" rowspan="1" |Attenuates different grades of steatosis, inflammation, and fibrosis in MAFLD patients | | colspan="1" rowspan="1" |Attenuates different grades of steatosis, inflammation, and fibrosis in MAFLD patients | ||
| colspan="1" rowspan="1" |Human trials | | colspan="1" rowspan="1" |Human trials | ||
|- | |- | ||
| colspan="1" rowspan="1" |Prevents adipose tissue dysfunction in ALD | | colspan="1" rowspan="1" |Prevents adipose tissue dysfunction in ALD | ||
| colspan="1" rowspan="1" |Male C57BL/6 mice | | colspan="1" rowspan="1" |Male C57BL/6 mice | ||
|- | |- | ||
| colspan="1" rowspan="1" |Reduces the inflammatory adipokines, IL6, TNFα, and leptin in human adipocytes | | colspan="1" rowspan="1" |Reduces the inflammatory adipokines, IL6, TNFα, and leptin in human adipocytes | ||
| colspan="1" rowspan="1" |Human visceral adipocytes | | colspan="1" rowspan="1" |Human visceral adipocytes | ||
|- | |- | ||
| colspan="1" rowspan="1" |Inhibits lipid peroxidation, hepatic inflammation, and expression of transforming growth factor-β1 in liver fibrosis | | colspan="1" rowspan="1" |Inhibits lipid peroxidation, hepatic inflammation, and expression of transforming growth factor-β1 in liver fibrosis | ||
| colspan="1" rowspan="1" |Male chicks | | colspan="1" rowspan="1" |Male chicks | ||
|- | |- | ||
| colspan="1" rowspan="1" | Suppresses alcoholic liver fibrosis | | colspan="1" rowspan="1" | Suppresses alcoholic liver fibrosis | ||
| colspan="1" rowspan="1" | Rats | | colspan="1" rowspan="1" | Rats | ||
|- | |- | ||
| colspan="1" rowspan="1" |Prevents the formation of Mallory–Denk bodies through epigenetic means by attenuating the decrease of MAT1A, SAHH, BHMT, and AMD1 expression | | colspan="1" rowspan="1" |Prevents the formation of Mallory–Denk bodies through epigenetic means by attenuating the decrease of MAT1A, SAHH, BHMT, and AMD1 expression | ||
| colspan="1" rowspan="1" |C3H male mice | | colspan="1" rowspan="1" |C3H male mice | ||
|- | |- | ||
| colspan="1" rowspan="1" |Reverses the inhibitory effects of acetaldehyde on IFN signaling and decreases de-methylation of STAT1 by JMJD6 | | colspan="1" rowspan="1" |Reverses the inhibitory effects of acetaldehyde on IFN signaling and decreases de-methylation of STAT1 by JMJD6 | ||
| colspan="1" rowspan="1" |HCV-infected Huh7.5 CYP2E1 (+) cells and human hepatocytes | | colspan="1" rowspan="1" |HCV-infected Huh7.5 CYP2E1 (+) cells and human hepatocytes | ||
|- | |- | ||
| colspan="1" rowspan="1" |Enhances expression of PPARα and elevates fatty acid catabolism | | colspan="1" rowspan="1" |Enhances expression of PPARα and elevates fatty acid catabolism | ||
| colspan="1" rowspan="1" |Male C57BL/6 and ApoE−/− mice | | colspan="1" rowspan="1" |Male C57BL/6 and ApoE−/− mice | ||
|- | |- | ||
| colspan="1" rowspan="1" |Inhibits lipogenic activity in liver by activation of AMPK | | colspan="1" rowspan="1" |Inhibits lipogenic activity in liver by activation of AMPK | ||
| colspan="1" rowspan="1" | ApoE−/− mice; Male C57BL/6 mice | | colspan="1" rowspan="1" | ApoE−/− mice; Male C57BL/6 mice | ||
|- | |- | ||
| colspan="1" rowspan="1" |Regulates colonic fluid balance | | colspan="1" rowspan="1" |Regulates colonic fluid balance | ||
| colspan="1" rowspan="1" |Rats | | colspan="1" rowspan="1" |Rats | ||
|- | |- | ||
| colspan="1" rowspan="1" |Improves intestinal barrier function and maintains the gut microbiota | | colspan="1" rowspan="1" |Improves intestinal barrier function and maintains the gut microbiota | ||
| colspan="1" rowspan="1" |Porcine epithelial cells; Caco-2 cells; rat small intestinal cell line IEC-18 | | colspan="1" rowspan="1" |Porcine epithelial cells; Caco-2 cells; rat small intestinal cell line IEC-18 | ||
|- | |- | ||
| colspan="1" rowspan="1" |Activates GI digestive enzymes and ameliorates intestinal morphology and microbiota dysbiosis | | colspan="1" rowspan="1" |Activates GI digestive enzymes and ameliorates intestinal morphology and microbiota dysbiosis | ||
| colspan="1" rowspan="1" |Male Sprague Dawley rats | | colspan="1" rowspan="1" |Male Sprague Dawley rats | ||
|- | |- | ||
| colspan="1" rowspan="1" | Attenuates alcoholic-induced pancreatic steatosis | | colspan="1" rowspan="1" | Attenuates alcoholic-induced pancreatic steatosis | ||
| colspan="1" rowspan="1" |Male Wistar rats | | colspan="1" rowspan="1" |Male Wistar rats | ||
|- | |- | ||
| colspan="1" rowspan="1" |Associated with resilience to anhedonia and prevention of stress-related psychiatric disorders | | colspan="1" rowspan="1" |Associated with resilience to anhedonia and prevention of stress-related psychiatric disorders | ||
| colspan="1" rowspan="1" |Male C57BL/6 mice | | colspan="1" rowspan="1" |Male C57BL/6 mice | ||
|- | |- | ||
| colspan="1" rowspan="1" | Treats asthma-induced oxidative stress, thus improving airway function of lung tissue | | colspan="1" rowspan="1" | Treats asthma-induced oxidative stress, thus improving airway function of lung tissue | ||
| colspan="1" rowspan="1" |BALB/C mice | | colspan="1" rowspan="1" |BALB/C mice | ||
|- | |- | ||
| colspan="1" rowspan="1" |Protects against cadmium nephrotoxicity | | colspan="1" rowspan="1" |Protects against cadmium nephrotoxicity | ||
| colspan="1" rowspan="1" |Male Wistar rats | | colspan="1" rowspan="1" |Male Wistar rats | ||
|- | |- | ||
| colspan="1" rowspan="1" |Protects against isoprenaline-induced myocardial dysfunction | | colspan="1" rowspan="1" |Protects against isoprenaline-induced myocardial dysfunction | ||
| colspan="1" rowspan="1" |Male Wistar rats | | colspan="1" rowspan="1" |Male Wistar rats | ||
|- | |- | ||
| colspan="1" rowspan="1" |Anti-nociceptive and sedative role via interactions with opioidergic and GABA receptors | | colspan="1" rowspan="1" |Anti-nociceptive and sedative role via interactions with opioidergic and GABA receptors | ||
| colspan="1" rowspan="1" |Male albino mice | | colspan="1" rowspan="1" |Male albino mice | ||
|- | |- | ||
| colspan="1" rowspan="1" |Normalizes fetal growth and reduces adiposity of progeny from obese mice | | colspan="1" rowspan="1" |Normalizes fetal growth and reduces adiposity of progeny from obese mice | ||
| colspan="1" rowspan="1" |C57BL/6J mice | | colspan="1" rowspan="1" |C57BL/6J mice | ||
|- | |- | ||
| colspan="1" rowspan="1" |Anti-cancer effect in alcohol-associated breast cancer cell growth and development | | colspan="1" rowspan="1" |Anti-cancer effect in alcohol-associated breast cancer cell growth and development | ||
| colspan="1" rowspan="1" |Breast adenocarcinoma cell line (MCF-7) | | colspan="1" rowspan="1" |Breast adenocarcinoma cell line (MCF-7) | ||
|- | |- | ||
| colspan="1" rowspan="1" |Reduces rectal temperature in broiler chickens | | colspan="1" rowspan="1" |Reduces rectal temperature in broiler chickens | ||
| colspan="1" rowspan="1" |Chickens | | colspan="1" rowspan="1" |Chickens | ||
|- | |- | ||
| colspan="1" rowspan="1" |Improves post-natal lamb survival | | colspan="1" rowspan="1" |Improves post-natal lamb survival | ||
| colspan="1" rowspan="1" |Lambs | | colspan="1" rowspan="1" |Lambs | ||
|} | |} | ||